Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis

oleh: Annika Klumpp, MD, Felix Luessi, MD, Sinah Engel, MD, Beate Weidenthaler-Barth, MD, Detlef Becker, MD, Stephan Grabbe, MD, Hadrian Schepler, MD

Format: Article
Diterbitkan: Elsevier 2022-10-01

Deskripsi

Subjek

anti-CD20 agent; multiple sclerosis; ocrelizumab; pyoderma gangrenosum